TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

James M. O’Brien Appointed Chief Financial Officer at Mesoblast

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Dr. Silviu Itescu
James M. O’Brien Appointed Chief Financial Officer at Mesoblast

Mesoblast Limited has appointed James M. O'Brien as its US-based Chief Financial Officer to support the company's transition to a fully integrated commercial organization, leveraging his extensive financial management experience in life sciences and biotechnology.

Insights
LULU   neutral

Facing challenges in North America with stock down 50%, but showing strong international growth, particularly in China, and implementing strategic initiatives to offset market pressures


MESO   positive

Company is expanding leadership, transitioning to commercial organization, and strengthening financial expertise with an experienced executive